Bruker Corp
BRKR
Market Cap$11.08B
Close$
$33.33
56% downside
Current Fair Value
56% downsideOvervalued by 56% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $11.08 Billion |
|---|---|
| Enterprise Value | $11.87 Billion |
| Dividend Yield | $0.1996 (0.26%) |
| Earnings per Share | $2.9 |
| Beta | 1.12 |
| Outstanding Shares | 145,334,691 |
| Avg 30 Day Volume | 1,257,079 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 25.93 |
|---|---|
| PEG | 23.36 |
| Price to Sales | 3.79 |
| Price to Book Ratio | 8.41 |
| Enterprise Value to Revenue | 4 |
| Enterprise Value to EBIT | 24.43 |
| Enterprise Value to Net Income | 27 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.93 |
Revenue Sources
No data
ESG Score
No data
About Bruker Corp
6,000 employees
CEO: Frank Laukien Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions enable...